Delivery Order SPE2DB25D7060-SPE2DB26FXSGZ
- Not listed
- The Defense Logistics Agency awarded a $8,058.96 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Atovaquone-Proguanil 250-100mg in quantities of 100 units. The contract, which represents a non-set-aside competitive award, is scheduled for completion by August 25, 2025, with performance to be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,343.16 to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Atovaquone-Proguanil 250-100mg in quantities of 100 tablets. The contract, which is firm fixed price with an ultimate completion date of April 24, 2025, carries no set-aside designation and was competitively awarded. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,343.16 on September 9, 2025, for Atovaquone-Proguanil 250-100 (100 tablets), with a completion date of September 10, 2025. This is a firm fixed-price delivery order under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical supply needs. The order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Atovaquone-Proguanil 250-100 mg tablets in quantities of 100 units, with a contract ceiling value of $27,644.83. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion by November 10, 2025, and will be performed at the contractor's Corporate Office...
- The Defense Logistics Agency awarded a $14,922.01 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 (100 tablets) on September 12, 2025, with a completion date of September 15, 2025. This is a firm fixed price order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $7,718.44 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Atovaquone-Proguanil 250-100mg in quantities of 100 tablets. This competitively awarded, firm fixed-price contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The work will be...
- The Defense Logistics Agency awarded a $33,579 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 in a quantity of 100 units. The contract, which was competitively awarded without set-aside designation, has an ultimate completion date of September 17, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $6,844.74 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 tablets (100 count) on October 16, 2025, with an ultimate completion date of October 17, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a small-value transaction under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $2,007.08 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 UD 24S, a pharmaceutical product used for malaria prophylaxis and treatment. This firm fixed price delivery order, issued on September 26, 2025, with an ultimate completion date of September 29, 2025, represents a non-competitive award under an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency (DLA) awarded a $1,426.28 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100 100S tablets on October 22, 2025, with completion expected by October 23, 2025. This competitively awarded, firm fixed-price delivery order represents a single pharmaceutical procurement under the company's broader relationship with DLA. The order is being fulfilled from AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, where...
- SPE2DB25D7060Indefinite Delivery Contract
- SPE2DB25D7060-SPE2DB26FXSGZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,479.30 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 in quantities of 100 units. The contract, awarded on November 12, 2025, with an ultimate completion date of November 13, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award status. Performance will be executed from the contractor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor specializing in pharmaceutical products and medical supplies for military and veteran healthcare systems. The Atovaquone-Proguanil antimalarial medication supplied under this order supports the broad medical supply needs of the Defense Health Agency and other government healthcare entities. As a prime vendor under the DLA Troop Support Medical IDC, the company maintains capability to supply a comprehensive range of pharmaceuticals, vaccines, and medical devices across multiple therapeutic domains to support military healthcare programs globally, with anticipated expansion through the planned Pharmaceutical Prime Vendor Global Program Generation V regional contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 11/12/25 |